CIK 0001006028
- Non-accelerated filer
- Smaller reporting company
PURE BIOSCIENCE, INC.
Sign in to watch- Ticker
- PURE
- Exchange
- OTC
- Industry
- Miscellaneous Chemical Products
- FY end
- Jul 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330530289
- Phone
- +1 619-596-8600
- Business address
- 771 JAMACHA ROAD #512, EL CAJON, CA, 92019
- Former names
- PURE BIOSCIENCE, INNOVATIVE MEDICAL SERVICES
- 4 Open-market buy Chief Executive Officer bought 78,721 shares at an average $0.66 ($52,248)
- 4 Other disposition Chief Executive Officer disposed of 10,732,222 shares (other)
- 4 Open-market buy Chief Executive Officer bought 53,124 shares at an average $1.76 ($93,570)
- 4 Grant or award Chief Operating Officer acquired 500,000 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 202,033 shares at an average $1.74 ($351,871)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,551,724 shares (grant or award)
- 4 Grant or award Director acquired 2,243,103 shares (grant or award)
- 4 Grant or award Director acquired 179,311 shares (grant or award)
- 4 Open-market sale Director sold 788,880 shares at an average $0.29 ($228,375)
- 4 Open-market buy Director bought 754,884 shares at $0.29 ($218,161)
- 4/A Grant or award Director acquired 862,068 shares (grant or award)
- 4/A Grant or award Director acquired 1,000,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 20 · 384 filings